Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registry.
Pfohl M, Pscherer S, Fritsche A, Anderten H, Borck A, Pegelow K, Bramlage P, Seufert J. Pfohl M, et al. Among authors: bramlage p. Diabetes Obes Metab. 2019 Sep;21(9):2169-2173. doi: 10.1111/dom.13768. Epub 2019 May 29. Diabetes Obes Metab. 2019. PMID: 31069944
Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases.
van Mark G, Lanzinger S, Barion R, Degenhardt M, Badis S, Noll H, Danne T, Bramlage P, Seufert J, Holl RW. van Mark G, et al. Among authors: bramlage p. Ther Adv Endocrinol Metab. 2019 Feb 28;10:2042018819830867. doi: 10.1177/2042018819830867. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 30834104 Free PMC article.
HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.
Fritsche A, Anderten H, Pfohl M, Pscherer S, Borck A, Pegelow K, Bramlage P, Seufert J. Fritsche A, et al. Among authors: bramlage p. BMJ Open Diabetes Res Care. 2019 Aug 1;7(1):e000668. doi: 10.1136/bmjdrc-2019-000668. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31423316 Free PMC article.
Treatment intensification strategies after initial metformin therapy in adult patients with type-2 diabetes: results of the DPV and DIVE registries.
Hartmann B, Lanzinger S, van Mark G, Wosch FJ, Durmaz M, Plaumann M, Sziegoleit S, Seufert J, Holl RW, Bramlage P; DPV and DIVE registry initiatives. Hartmann B, et al. Among authors: bramlage p. Acta Diabetol. 2020 Feb;57(2):229-236. doi: 10.1007/s00592-019-01409-3. Epub 2019 Aug 30. Acta Diabetol. 2020. PMID: 31471633 Clinical Trial.
The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany.
Bramlage P, Tittel SR, Wagner C, König K, Raddatz D, Weber-Lauffer R, Erath D, Hilgenberg J, Spies C, Danne T, Gabler M, Foersch J, Ley L, Seufert J. Bramlage P, et al. BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001486. doi: 10.1136/bmjdrc-2020-001486. BMJ Open Diabetes Res Care. 2020. PMID: 32719080 Free PMC article.
485 results